News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,081 Results
Type
Article (44272)
Company Profile (347)
Press Release (573452)
Multimedia
Podcasts (103)
Webinars (16)
Section
Business (168480)
Career Advice (2460)
Deals (30476)
Drug Delivery (116)
Drug Development (79151)
Employer Resources (148)
FDA (14661)
Job Trends (13076)
News (297669)
Policy (28745)
Tag
Academia (2687)
Academic (1)
Accelerated approval (26)
Adcomms (31)
Allergies (127)
Alliances (43148)
ALS (168)
Alzheimer's disease (1699)
Antibody-drug conjugate (ADC) (294)
Approvals (14822)
Artificial intelligence (467)
Autoimmune disease (123)
Automation (29)
Bankruptcy (327)
Best Places to Work (10686)
BIOSECURE Act (17)
Biosimilars (165)
Biotechnology (259)
Bladder cancer (149)
Brain cancer (56)
Breast cancer (598)
Cancer (4488)
Cardiovascular disease (383)
Career advice (2086)
Career pathing (37)
CAR-T (276)
CDC (43)
Cell therapy (719)
Cervical cancer (30)
Clinical research (67033)
Collaboration (1489)
Company closure (4)
Compensation (770)
Complete response letters (58)
COVID-19 (2674)
CRISPR (91)
C-suite (734)
Cystic fibrosis (141)
Data (5750)
Decentralized trials (2)
Denatured (21)
Depression (128)
Diabetes (462)
Diagnostics (6072)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (41)
Drug discovery (230)
Drug pricing (167)
Drug shortages (25)
Duchenne muscular dystrophy (223)
Earnings (64767)
Editorial (53)
Employer branding (20)
Employer resources (139)
Events (94022)
Executive appointments (978)
FDA (17350)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1311)
Gene editing (194)
Generative AI (41)
Gene therapy (588)
GLP-1 (962)
Government (4479)
Grass and pollen (7)
Guidances (372)
Healthcare (17312)
HIV (49)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (257)
Immuno-oncology (38)
Indications (75)
Infectious disease (2922)
Inflammatory bowel disease (192)
Inflation Reduction Act (15)
Influenza (104)
Intellectual property (214)
Interviews (527)
IPO (14372)
IRA (52)
Job creations (2766)
Job search strategy (1688)
Kidney cancer (17)
Labor market (58)
Layoffs (546)
Leadership (38)
Legal (6108)
Liver cancer (90)
Longevity (11)
Lung cancer (634)
Lymphoma (347)
Machine learning (35)
Management (52)
Manufacturing (639)
MASH (166)
Medical device (11408)
Medtech (11443)
Mergers & acquisitions (17028)
Metabolic disorders (1192)
Multiple sclerosis (142)
NASH (23)
Neurodegenerative disease (302)
Neuropsychiatric disorders (85)
Neuroscience (2852)
NextGen: Class of 2025 (5987)
Non-profit (4144)
Now hiring (55)
Obesity (554)
Opinion (282)
Ovarian cancer (150)
Pain (179)
Pancreatic cancer (198)
Parkinson's disease (265)
Partnered (30)
Patents (442)
Patient recruitment (401)
Peanut (56)
People (55615)
Pharmaceutical (54)
Pharmacy benefit managers (21)
Phase I (21055)
Phase II (29583)
Phase III (22051)
Pipeline (3842)
Policy (266)
Postmarket research (2393)
Preclinical (8934)
Press Release (60)
Prostate cancer (217)
Psychedelics (52)
Radiopharmaceuticals (277)
Rare diseases (774)
Real estate (4544)
Recruiting (63)
Regulatory (22038)
Reports (30)
Research institute (2328)
Resumes & cover letters (361)
Rett syndrome (24)
RNA editing (16)
RSV (67)
Schizophrenia (145)
Series A (221)
Series B (167)
Service/supplier (3)
Sickle cell disease (96)
Special edition (20)
Spinal muscular atrophy (160)
Sponsored (37)
Startups (3220)
State (2)
Stomach cancer (17)
Supply chain (88)
Tariffs (72)
The Weekly (81)
Vaccines (935)
Venture capital (78)
Weight loss (374)
Women's health (62)
Worklife (18)
Date
Last 7 days (509)
Last 30 days (2046)
Last 365 days (29046)
2025 (28808)
2024 (33636)
2023 (37508)
2022 (48423)
2021 (52034)
2020 (50022)
2019 (42561)
2018 (32079)
2017 (29665)
2016 (28197)
2015 (32982)
2014 (25392)
2013 (20587)
2012 (21791)
2011 (22691)
2010 (20433)
Location
Africa (756)
Alabama (79)
Alaska (4)
Arizona (218)
Arkansas (12)
Asia (37603)
Australia (7416)
California (9683)
Canada (2988)
China (988)
Colorado (395)
Connecticut (392)
Delaware (310)
Europe (84564)
Florida (1442)
Georgia (304)
Hawaii (2)
Idaho (59)
Illinois (734)
India (55)
Indiana (436)
Iowa (17)
Japan (368)
Kansas (113)
Kentucky (32)
Louisiana (24)
Maine (58)
Maryland (1241)
Massachusetts (7080)
Michigan (281)
Minnesota (524)
Mississippi (5)
Missouri (119)
Montana (26)
Nebraska (23)
Nevada (101)
New Hampshire (74)
New Jersey (2706)
New Mexico (25)
New York (2587)
North Carolina (1283)
North Dakota (7)
Northern California (4564)
Ohio (269)
Oklahoma (16)
Oregon (36)
Pennsylvania (1960)
Puerto Rico (19)
Rhode Island (40)
South America (1019)
South Carolina (55)
South Dakota (1)
Southern California (3846)
Tennessee (144)
Texas (1511)
United States (34721)
Utah (297)
Vermont (1)
Virginia (219)
Washington D.C. (69)
Washington State (810)
West Virginia (4)
Wisconsin (86)
Wyoming (2)
618,081 Results for "akashi therapeutics formerly known as dart therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
December 12, 2025
·
6 min read
Press Releases
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 5, 2025
·
5 min read
Press Releases
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025
November 20, 2025
·
6 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
December 19, 2025
·
5 min read
Press Releases
Plus Therapeutics Expands CNSide Assay Platform to State of California
December 11, 2025
·
5 min read
Press Releases
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting
November 11, 2025
·
10 min read
Press Releases
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
June 4, 2025
·
4 min read
Press Releases
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
December 18, 2025
·
6 min read
1 of 61,809
Next
